SCHEMBL6101344

SCHEMBL6101344

O=C1c2c(c(O)c3c(F)cccc3c2O)C(=O)N1Cc1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 2/20 0.45
LMNA P02545 2/20 0.44
HPGD P15428 1/20 0.44
UBE2N P61088 1/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPT P10636 2/20 0.41
HTT P42858 2/20 0.41
MEN1 O00255 1/20 0.41
RGS12 O14924 1/20 0.41
USP2 O75604 1/20 0.41
RECQL P46063 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
CLTC Q00610 1/20 0.39
NQO1 P15559 1/20 0.39
CHRM5 P08912 2/20 0.38
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6099552 0.86 CASP3 (0.55) CASP3LMNAHPGDUBE2NATM
SCHEMBL4150453 0.77 CYP1A2 (0.54) CASP3LMNAL3MBTL1MAPTHTT
SCHEMBL5793783 0.76 KMT2A (0.39) CASP3LMNAHPGDATMMAPT
SCHEMBL2643289 0.75 CASP3 (0.63) CASP3LMNAHPGDUBE2NATM
SCHEMBL14260126 0.73 CYP1A2 (0.50) CASP3LMNAL3MBTL1MAPTHTT
SCHEMBL4150996 0.72 CYP1A2 (0.51) CASP3LMNAHPGDUBE2NATM
SCHEMBL4377121 0.72 CASP3 (0.60) CASP3LMNAHPGDUBE2NATM
SCHEMBL14260606 0.72 CYP1A2 (0.42) CASP3LMNAHPGDUBE2NATM
SCHEMBL4689945 0.72 CASP3 (0.40) CASP3LMNAHPGDUBE2NATM
SCHEMBL6099928 0.71 THRB (0.42) CASP3LMNAHPGDUBE2NATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060211724-A1 Hiv integrase inhibitors VERSCHUEREN GASTON W 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211724-A1 Hiv integrase inhibitors SULT1A1, SULT2A1, SULT1E1 CASP3 3629/4885LMNA 3986/4885HPGD 347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.